Clot Management Devices

Clot Management Devices

Global Clot Management Devices Market to Reach $2.3 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Clot Management Devices estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.3 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$850.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Catheter-Directed Thrombolysis (CDT) Devices segment is readjusted to a revised 3.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $493.1 Million, While China is Forecast to Grow at 4.1% CAGR

The Clot Management Devices market in the U.S. is estimated at US$493.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$400.8 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.Inferior Vena Cava Filters (IVCF) Segment to Record 4% CAGR

In the global Inferior Vena Cava Filters (IVCF) segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$229.8 Million in the year 2020 will reach a projected size of US$304 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 11 Featured) -

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular S.L.U
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Clot Management Devices – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Neurovascular Embolectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Percutaneous Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Embolectomy Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Inferior Vena Cava Filters (IVCF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 25: World Clot Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 27: USA Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 28: USA 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 29: USA Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 30: USA Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 31: USA 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 33: Canada Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 34: Canada 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 35: Canada Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 36: Canada Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 37: Canada 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
JAPAN
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 39: Japan Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 40: Japan 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 41: Japan Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 42: Japan Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 43: Japan 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
CHINA
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 44: China Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 45: China Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 46: China 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 47: China Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 48: China Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 49: China 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
EUROPE
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 51: Europe Historic Review for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 52: Europe 15-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 53: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 54: Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 55: Europe 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 56: Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 57: Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 58: Europe 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
FRANCE
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 59: France Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 60: France Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 61: France 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 62: France Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 63: France Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 64: France 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
GERMANY
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 66: Germany Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 67: Germany 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 68: Germany Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 69: Germany Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 70: Germany 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
ITALY
TABLE 71: Italy Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 72: Italy Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 73: Italy 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 74: Italy Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 75: Italy Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 76: Italy 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
UNITED KINGDOM
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 78: UK Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 79: UK 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 80: UK Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 81: UK Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 82: UK 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 84: Rest of Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 85: Rest of Europe 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 87: Rest of Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 88: Rest of Europe 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 90: Asia-Pacific Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 91: Asia-Pacific 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 94: Asia-Pacific 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 95: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 96: Rest of World Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 97: Rest of World 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2012, 2021 & 2027
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 99: Rest of World Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 100: Rest of World 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings